drugset / Trial / NCT01608711
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to continue the safety and immunogenicity of AGS-1C4D4 administered in combination with gemcitabine in subjects previously treated in protocol 2008002.
Timeline
- Start
- 2012-08-07
- Primary completion
- 2015-11-16
- Completion
- 2015-11-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-4721 | Unknown | — | Intravenous |
| Background | Gemcitabine | Small molecule | — | Intravenous |